Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Emanuela,Rossi ^[1] ; Assunta,Sgambato ^[2] ; Giovanni,De Chiara ^[3] ; Francesca,Casaluce ^[2] ; Tania,Losanno ^[4] ; Paola Claudia,Sacco ^[1] ; Giuseppe,Santabarbara ^[1] ; Cesare,Gridelli ^[1]

作者单位： a Division of Medical Oncology , "S. G. Moscati" Hospital , Avellino , Italy. ^[1] b Department of Clinical and Experimental Medicine , Second University of Naples , Naples , Italy. ^[2] c Division of Pathologic Anatomy , "S. G. Moscati" Hospital , Avellino , Italy. ^[3] d Department of Experimental Medicine , "Sapienza" University , Rome , Italy. ^[4]

关键词 CTLA-4 NSCLC PD-1 PD-L1 endocrine toxicities immunotherapy

主题词抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);内分泌系统疾病(Endocrine System Diseases);人类(Humans);免疫疗法(Immunotherapy);肺肿瘤(Lung Neoplasms)

DOI 10.1586/17512433.2016.1133289

PMID 26681547

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交